These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 32790406)
21. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2 Li Z; Zhang JZH Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759 [TBL] [Abstract][Full Text] [Related]
22. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Wang Q; Zhang Y; Wu L; Niu S; Song C; Zhang Z; Lu G; Qiao C; Hu Y; Yuen KY; Wang Q; Zhou H; Yan J; Qi J Cell; 2020 May; 181(4):894-904.e9. PubMed ID: 32275855 [TBL] [Abstract][Full Text] [Related]
23. Structural characteristics of BtKY72 RBD bound to bat ACE2 reveal multiple key residues affecting ACE2 usage of sarbecoviruses. Su C; He J; Wang L; Hu Y; Cao J; Bai B; Qi J; Gao GF; Yang M; Wang Q mBio; 2024 Sep; 15(9):e0140424. PubMed ID: 39082798 [TBL] [Abstract][Full Text] [Related]
24. Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study. Yang Y; Zhang Y; Qu Y; Zhang C; Liu XW; Zhao M; Mu Y; Li W Nanoscale; 2021 May; 13(20):9364-9370. PubMed ID: 33999091 [TBL] [Abstract][Full Text] [Related]
25. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins. Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301 [TBL] [Abstract][Full Text] [Related]
26. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness. Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316 [TBL] [Abstract][Full Text] [Related]
27. Interfacial Water in the SARS Spike Protein: Investigating the Interaction with Human ACE2 Receptor and In Vitro Uptake in A549 Cells. Singh AV; Kayal A; Malik A; Maharjan RS; Dietrich P; Thissen A; Siewert K; Curato C; Pande K; Prahlad D; Kulkarni N; Laux P; Luch A Langmuir; 2022 Jul; 38(26):7976-7988. PubMed ID: 35736838 [TBL] [Abstract][Full Text] [Related]
29. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states. Peters MH; Bastidas O; Kokron DS; Henze CE PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884 [TBL] [Abstract][Full Text] [Related]
30. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. Wang S; Guo F; Liu K; Wang H; Rao S; Yang P; Jiang C Virus Res; 2008 Sep; 136(1-2):8-15. PubMed ID: 18554741 [TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection. Tan HW; Xu YM; Lau ATY Rev Med Virol; 2020 Sep; 30(5):e2122. PubMed ID: 32602627 [TBL] [Abstract][Full Text] [Related]
32. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. Song W; Gui M; Wang X; Xiang Y PLoS Pathog; 2018 Aug; 14(8):e1007236. PubMed ID: 30102747 [TBL] [Abstract][Full Text] [Related]
33. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction. Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086 [TBL] [Abstract][Full Text] [Related]
34. In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding. Bate N; Savva CG; Moody PCE; Brown EA; Evans SE; Ball JK; Schwabe JWR; Sale JE; Brindle NPJ PLoS Pathog; 2022 Jul; 18(7):e1010733. PubMed ID: 35849637 [TBL] [Abstract][Full Text] [Related]
35. Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study. Dehury B; Raina V; Misra N; Suar M J Biomol Struct Dyn; 2021 Nov; 39(18):7231-7245. PubMed ID: 32762417 [TBL] [Abstract][Full Text] [Related]
36. Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates. Alazmi M; Motwalli O J Mol Model; 2020 Nov; 26(12):338. PubMed ID: 33175236 [TBL] [Abstract][Full Text] [Related]
37. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method. Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344 [TBL] [Abstract][Full Text] [Related]
38. Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states. Gur M; Taka E; Yilmaz SZ; Kilinc C; Aktas U; Golcuk M J Chem Phys; 2020 Aug; 153(7):075101. PubMed ID: 32828084 [TBL] [Abstract][Full Text] [Related]
39. All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein Complexes. Dutta S; Panthi B; Chandra A J Phys Chem B; 2022 Jul; 126(29):5375-5389. PubMed ID: 35833966 [TBL] [Abstract][Full Text] [Related]